Leap reverse merges, secures $30M for I/O antibodies | Fierce Biotech
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat | Nasdaq
pbyi buyout Off 77%
The 10 Annual BIO Investor Forum – Program Business Roundtable Therapeutic Workshop
pbyi buyout Off 77%
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Biotechnology: Alisertib Deal Alters My Strategy (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. | LinkedIn
DFAN14A
Institutional investors own a significant stake of 45% in Puma Biotechnology, Inc. (NASDAQ:PBYI)
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology
Puma Biotechnology, Inc. 2022 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
From summer lull to biotech's record-breaking month | Evaluate
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
From Public To Private, Crossover Investors Are Back In Biotech :: Scrip
FDA panel backs Puma's neratinib, clearing path to approval | Fierce Biotech
Puma investors look for second lightning strike | Evaluate
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology, Inc. (PBYI) Stock Price Today, Quote & News | Seeking Alpha
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
Articles with Puma Biotechnology
Gordon Esplin - Chief Accounting Officer - Puma Biotechnology, Inc. | LinkedIn
Finance Watch: Biopharma IPO Market Silence Continues In The US :: Scrip
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology, Inc. 2022 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
